Canadian clinical-stage biopharmaceutical company BioVaxys Technology Corp (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) announced on Thursday the appointment of Brittany Davison, CPA, CA as its new business advisor.
Davison, a chartered professional accountant, is the owner of Davison CPA Consulting Inc of Halifax, Nova Scotia. She previously served as chief accounting officer and acting chief financial officer at IMV Inc and as audit senior with Grant Thornton LLP.
Kenneth Kovan, BioVaxys president & chief operating officer, said: "We are delighted to have engaged Brittany who is a significant addition to our team where she will assist with further knowledge transfer associated with the former IMV Inc assets, support investor relations, business development targeting and outreach, and facilitate sources of private funding, government funding and Scientific Research and Experimental Development (SR&ED) tax incentives."
PTC Therapeutics' Sephience receives US FDA approval to treat phenylketonuria
Zymeworks receives FDA clearance for ZW251 investigational new drug application
GEN and Sulfateq report positive Phase 1 data for SUL-238 in Alzheimer's
Deciphera receives positive CHMP opinion for ROMVIMZA in tenosynovial giant cell tumor
NFL Biosciences and McLean Hospital collaborate to advance NFL-101 mechanism research
BeOne Medicines secures CHMP backing for TEVIMBRA in early-stage NSCLC
Ascletis reports first participants dosed in Phase IIa study of GLP-1R agonist ASC30
Hengrui Pharma and GSK to jointly develop up to 12 innovative medicines